BIOMAT Database Logo BIOMAT Database Logo

Computer-aided identification, synthesis and evaluation of substituted thienopyrimidines as novel inhibitors of HCV replication. 2016

Marcella Bassetto, and Pieter Leyssen, and Johan Neyts, and Mark M Yerukhimovich, and David N Frick, and Andrea Brancale
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff, King Edward VII Avenue, Cardiff, CF103NB, UK. Electronic address: bassettom@cardiff.ac.uk.

A structure-based virtual screening technique was applied to the study of the HCV NS3 helicase, with the aim to find novel inhibitors of the HCV replication. A library of ∼450000 commercially available compounds was analysed in silico and 21 structures were selected for biological evaluation in the HCV replicon assay. One hit characterized by a substituted thieno-pyrimidine scaffold was found to inhibit the viral replication with an EC50 value in the sub-micromolar range and a good selectivity index. Different series of novel thieno-pyrimidine derivatives were designed and synthesised; several new structures showed antiviral activity in the low or sub-micromolar range.

UI MeSH Term Description Entries
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D017076 Computer-Aided Design The use of computers for designing and/or manufacturing of anything, including drugs, surgical procedures, orthotics, and prosthetics. CAD-CAM,Computer-Aided Manufacturing,Computer-Assisted Design,Computer-Assisted Manufacturing,Computer Aided Design,Computer Aided Manufacturing,Computer Assisted Design,Computer Assisted Manufacturing,Computer-Aided Designs,Computer-Assisted Designs,Design, Computer-Aided,Design, Computer-Assisted,Designs, Computer-Aided,Designs, Computer-Assisted,Manufacturing, Computer-Aided,Manufacturing, Computer-Assisted
D017361 Viral Nonstructural Proteins Proteins encoded by a VIRAL GENOME that are not structural components of VIRUS PARTICLES. Some of these proteins may play roles within the infected cell during VIRUS REPLICATION or act in regulation of virus replication or VIRUS ASSEMBLY. Nonstructural Proteins, Viral,NS Proteins, Viral,Viral NS Proteins,Viral Non-Structural Proteins,Viral Nonstructural Protein,Viral Nonstructural Proteins NS1,Viral Nonstructural Proteins NS2,Nonstructural Protein, Viral,Viral Non Structural Proteins
D046609 Libraries, Digital Libraries in which a major proportion of the resources are available in machine-readable format, rather than on paper or MICROFORM. Digital Libraries,Libraries, Virtual,Digital Library,Library, Digital,Library, Virtual,Virtual Libraries,Virtual Library

Related Publications

Marcella Bassetto, and Pieter Leyssen, and Johan Neyts, and Mark M Yerukhimovich, and David N Frick, and Andrea Brancale
Novel substituted pyrimidines as HCV replication (replicase) inhibitors.
January 2012, Bioorganic & medicinal chemistry letters,
Marcella Bassetto, and Pieter Leyssen, and Johan Neyts, and Mark M Yerukhimovich, and David N Frick, and Andrea Brancale
Synthesis and evaluation of novel HCV replication inhibitors.
May 2017, Molecular diversity,
Marcella Bassetto, and Pieter Leyssen, and Johan Neyts, and Mark M Yerukhimovich, and David N Frick, and Andrea Brancale
Computer-aided identification, synthesis, and biological evaluation of novel inhibitors for botulinum neurotoxin serotype A.
September 2015, Bioorganic & medicinal chemistry,
Marcella Bassetto, and Pieter Leyssen, and Johan Neyts, and Mark M Yerukhimovich, and David N Frick, and Andrea Brancale
Substituted imidazopyridines as potent inhibitors of HCV replication.
May 2009, Journal of hepatology,
Marcella Bassetto, and Pieter Leyssen, and Johan Neyts, and Mark M Yerukhimovich, and David N Frick, and Andrea Brancale
Design, Synthesis, and Biological Evaluation of Dimorpholine Substituted Thienopyrimidines as Potential Class I PI3K/mTOR Dual Inhibitors.
May 2017, Journal of medicinal chemistry,
Marcella Bassetto, and Pieter Leyssen, and Johan Neyts, and Mark M Yerukhimovich, and David N Frick, and Andrea Brancale
Design, synthesis and biological evaluation of some novel thienopyrimidines and fused thienopyrimidines as anti-inflammatory agents.
September 2012, European journal of medicinal chemistry,
Marcella Bassetto, and Pieter Leyssen, and Johan Neyts, and Mark M Yerukhimovich, and David N Frick, and Andrea Brancale
Synthesis and SAR of pyridothiazole substituted pyrimidine derived HCV replication inhibitors.
September 2012, Bioorganic & medicinal chemistry letters,
Marcella Bassetto, and Pieter Leyssen, and Johan Neyts, and Mark M Yerukhimovich, and David N Frick, and Andrea Brancale
Computer-aided drug design, synthesis and identification of disulfide compounds as novel and potential allosteric PAK1 inhibitors.
March 2018, RSC advances,
Marcella Bassetto, and Pieter Leyssen, and Johan Neyts, and Mark M Yerukhimovich, and David N Frick, and Andrea Brancale
Design and synthesis of novel annulated thienopyrimidines as phosphodiesterase 5 (PDE5) inhibitors.
May 2018, Archiv der Pharmazie,
Marcella Bassetto, and Pieter Leyssen, and Johan Neyts, and Mark M Yerukhimovich, and David N Frick, and Andrea Brancale
Thienopyrimidines as novel inhibitors of Mycobacterium tuberculosis: synthesis and in-vitro studies.
July 2011, Archiv der Pharmazie,
Copied contents to your clipboard!